

Chinese Journal of Pharmacovigilance ›› 2026, Vol. 23 ›› Issue (6): 630-635.
DOI: 10.19803/j.1672-8629.20250705
Previous Articles Next Articles
BAI Xue, LI Xueli*
Received:2025-10-11
Online:2026-06-15
Published:2026-06-18
CLC Number:
BAI Xue, LI Xueli. Research Progress in Active Ingredients of Ginseng and Salvia Miltiorrhiza and Its Therapeutic Effect against Coronary Heart Disease[J]. Chinese Journal of Pharmacovigilance, 2026, 23(6): 630-635.
| [1] LIU MB, HE XY, YANG XH, et al.Interpretation of Report on Cardiovascular Health and Diseases in China 2023[J]. Chinese Journal of Interventional Cardiology(中国介入心脏病学杂志), 2024, 32(10): 541-550. [2] LI XR, ZHAI XQ, XU HF.New Advances in the Treatment of Coronary Heart Disease of the Qi Deficiency and Blood Stasis Syndrome with the Yiqi Huoxue Prescription[J]. Clinical Journal of Chinese Medicine(中医临床研究), 2024, 16(8): 75-81. [3] HU RR, FU H, HAN XY, et al.Research Progress on the Pharmacological Effects and Clinical Studies of Salvia Miltiorrhiza Drug Pairs and Preparations in Cardiovascular Protection[J]. Acta Chinese Medicine and Pharmacology(中医药学报), 2023, 51(5): 106-110. [4] LI ZB, ZHENG YQ.Research Progress on Pharmacological Mechanisms of Salviae Miltiorrhizae Radix et Rhizoma and Its Active Components in Modulating Vascular Endothelial Cell Functions[J]. Chinese Traditional and Herbal Drugs, 2025, 56(14): 5324-5332. [5] QU Y, WANG T, FU HJ, et al.Research Progress on the Active Ingredients and Pharmacological Effects of Danshen (Salviae Miltiorrhizae)[J]. Journal of Liaoning University of Traditional Chinese Medicine(辽宁中医药大学学报), 2024, 26(9): 172-176. [6] YAO CP.Huang Di Nei Jing (黄帝内经)[M]. Beijing: Chung Hwa Book Company Limited, 2010. [7] ZHANG ZJ.Essentials from the Golden Cabinet (金匮要略)[M]. Beijing: People’s Medical Publishing House, 2005. [8] PAN Y, ZHOU MX, GUO JJ.Research on Qi-Tonifying and Blood-Activating Traditional Chinese Medicines for the Prevention and Treatment of Atherosclerosis[J]. Journal of Basic Chinese Medicine(中国中医基础医学杂志), 2021, 27(2): 362-366. [9] GAO W, DAI G, ZHANG T, et al.Tonifying Qi and Activating Blood Circulation in Terms of Traditional Chinese Medicine: Effects in Patients with Myocardial Infarction[J]. Journal of Traditional Chinese Medicine, 2018, 38(5): 726-732. [10] MIAO XY.Shen Nong Materia Medica(神农本草经疏)[M]. Beijing: Publishing House of Ancient Chinese Medical Books, 2017. [11] WANG HY.Taiping Sheng Hui Fang(太平圣惠方)[M]. Beijing: People’s Medical Publishing House, 2016. [12] HUANG S, LIU JX, LI L, et al.Effects of Shuangshen Tongguan Formula on the Rat Model of Coronary Heart Disease with Syndrome of Blood Stasis due to Qi Deficiency[J]. China Journal of Traditional Chinese Medicine and Pharmacy(中华中医药杂志), 2017, 32(7): 3109-3116. [13] LIU W, LIU YB, WANG Z, et al.Research Progress of Chemical Composition of Ginseng and Its Transformation Mechanism[J]. Journal of Jilin Agricultural University(吉林农业大学学报), 2023, 45(6): 664-673. [14] WANG LY, GU XY, CUI Y, et al.Mechanism of Ginsenoside Rb1 in Ameliorating Hypoxia/Reoxygenation Injury in H9c2 Cardiomyocytes through CTR1 Ubiquitination-Mediated Regulation of Cuproptosis[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2025, 50(17): 4841-4851. [15] HAN M, LI YJ, YANG GN, et al.The Mechanism of Ginsenosides Inhibiting Myocardial Autophagy in Chronic Heart Failure Rats through JAK/STAT Signaling Pathway[J]. Shaanxi Medical Journal(陕西医学杂志), 2025, 54(1): 33-37. [16] ZHOU Z, SONG Z, GUO X, et al . Ginsenoside Rb1 Ameliorates Heart Failure Ventricular Remodeling by Regulating the Twist1/PGC-1α/PPARα Signaling Pathway[J]. Pharmaceuticals (Basel), 2025, 18(4): 500. [17] DU Q, CHAI H, LI XH, et al.Effects and Mechanism of Ginsenoside Rb1 Ischaemia Postconditioning on Ventricular Arrhythmias Induced by Acute Ischemia-Reperfusion in Rats[J]. Medical Journal of Wuhan University(武汉大学学报医学版), 2025, 46(4): 438-445. [18] FAN L, ZHU X, LIANG HY, et al. Ginsenoside Rg1 Improves Chronic Myocardial Inflammatory Injury and Fibrosis by Inhibiting AIM2/NLRP3 Inflammasomes in Mice[J/OL]. Chinese Pharmacological Bulletin(中国药理学通报), (2025-11-18)[2025-11-18]. http://kns.cnki.net/kcms/detail/34.1086.R.20250828.1657.002.html. [19] MA XM, LIU ZS, DU G, et al.Effect of Sodium TanshinoneⅡA Sulfonate Combined with Aspirin on Cardiac Function in Patients with Angina Pectoris of Coronary Heart Disease[J]. Clinical Medication Journal(临床药物治疗杂志), 2024, 22(2): 41-45. [20] ZHOU FJ, LYU Y, ZHANG J.Efficacy of Sodium TanshinoneⅡA Sulfonate Combined with Nicorandil for Stable Angina Pectoris and Cardiac Function in Patients with CHD[J]. Chinese Journal of Geriatric Heart Brain and Vessel Diseases(中华老年心脑血管病杂志), 2024, 26(11): 1301-1305. [21] ZHOU L, LI BY, GU XF, et al.TanshinoneⅡA Attenuates Myocardial Ischemia-Reperfusion Induced Arrhythmias in Rats via PKC/CX43 Pathway[J]. Drug Evaluation Research(药物评价研究), 2023, 46(12): 2617-2623. [22] ZHANG LL, XIE ZL, QUAN XQ, et al.TanshinoneⅡA Ameliorates Ischemia/Reperfusion Injury in H9c2 Cardiomyocytes by Activating SIRT1-AMPK Pathway via miR-155-5p[J]. Chinese Journal of Immunology(中国免疫学杂志), 2023, 39(12): 2507-2512. [23] LI Y, LU ML, WANG HX, et al. TanshinoneⅡA Attenuates Myocardial Ischemia-Reperfusion Injury through Regulating Calpain-1[J/OL]. Pharmacology and Clinics of Chinese Materia Medica(中药药理与临床), (2025-11-18)[2025-11-18]. https://doi.org/10.13412/j.cnki.zyyl.20250929.007. [24] QIAO P, XU J, LIU X, et al.TanshinoneⅡA Improves Ventricular Remodeling Following Cardiac Infarction by Regulating miR-205-3p[J]. Dis Markers, 2021, 2021: 8740831. [25] YAN N, XIAO C, WANG X, et al.TanshinoneⅡA from Salvia Miltiorrhiza Exerts Anti-Fibrotic Effects on Cardiac Fibroblasts and Rat Heart Tissues by Suppressing the Levels of Pro-Fibrotic Factors: The Key Role of miR-618[J]. J Food Biochem, 2022, 46(2): 14078. [26] ZHANG CR.Study on the Medication Regularity and Network Pharmacology of Authorized TCM Patent Compounds in Treating Angina Pectoris of Coronary Heart Disease[D]. Guangzhou: Guangzhou University of Chinese Medicine, 2024. [27] YANG J, LI J, LI L, et al.Mechanism of Herbal Pairs with the Properties of Qi-Tonifying, Blood Activation, and Blood-Stasis Breaking in Treating Coronary Heart Disease[J]. Chinese Journal of Integrative Medicine, 2017, 37(2): 269-278. [28] LI CH, CHEN Q, KANG L, et al.The Molecular Mechanism of Panax Ginseng, Radix Salviae, and Lepidii Semen Descurainiae Semen in Treating Chronic Heart Failure Based on Network Pharmacology and Molecular Docking[J]. Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease(中西医结合心脑血管病杂志), 2022, 20(21): 3855-3863. [29] XIN GJ, ZHAO YW, LI LM, et al.Mechanism of“Invigorating Qi and Promoting Blood Circulation”Drug Pair Ginseng-Danshen in the Treatment of Ischemic Heart Disease Based on Network Pharmacology[J]. Chinese Journal of Integrative Medicine, 2021, 27(6): 440-445. [30] WANG J, ZHANG L, WANG SQ, et al. Ginseng Radix et Rhizoma-Salviae Miltiorrhizae Radix et Rhizoma Inhibits Inflammatory Response against Doxorubicin-Induced Myocardial Injury through the TLR4/NF-κB Pathway[J/OL]. Natural Product Research and Development(天然产物研究与开发), (2025-10-28)[2025-11-27]. http://kns.cnki.net/kcms/detail/51.1335.Q.20251027.1750.006.html. [31] LIN L, LIU JX, ZHANG Y, et al.A PK/PD Data Processing Study on Chinese Formulation of Shuang-Shen-Tong-Guan Prescription[J]. Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology(世界科学技术中医药现代化), 2012, 14(3): 1583-1589. [32] LIAO JG, LI MY, XIE ZF, et al.Protective Effects and Mechanisms of Ginsenoside Rg1 Combined with TanshinoneⅡA on H9c2 Cells Treated by Hypoxia-Reoxygenation[J]. China Journal of Modern Medicine(中国现代医学杂志), 2014, 24(22): 13-16. [33] WEI Y, WANG YY, WU Q, et al.Effect of Total Ginsenosides on Cardiac Function and Ventricular Remodeling in Rats with Acute Myocardial Infarction[J]. Practical Pharmacy and Clinical Remedies(实用药物与临床), 2017, 20(5): 497-501. [34] WEN J.Study on the Mechanism of Anti-Myocardial Ischemia-Reperfusion Effects of Total Salvianolic Acids Based on Sarcoplasmic Reticulum-Mitochondria Interaction[D]. Beijing: China Academy of Chinese Medical Sciences, 2023. [35] LI L, MENG HX, XIN GJ, et al.Effect of Shuangshen Ningxin Capsules on Cardiac Function and Hemodynamics in Rats with Coronary Microvascular Dysfunction[J]. Chinese Journal of Experimental Traditional Medical Formulae(中国实验方剂学杂志), 2021, 27(22): 41-50. [36] KANG J, YANG LL, SHI Y, et al.Study on the Mechanism of Shuangshen Ningxin Capsules in Treating Coronary Microvascular Disease Based on Transcriptomic[J]. Chinese Journal of Information on Traditional Chinese Medicine(中国中医药信息杂志), 2024, 31(11): 116-122. [37] LI LM.Study on the Mechanism of Shuangshen Ningxin Capsule Regulating NLRP3 Inflammasome against Myocardial Ischemia/Reperfusion Injury[D]. Beijing: China Academy of Chinese Medical Sciences, 2023. [38] XIN GJ.Protective Effects of Shuangshen Ningxin Capsule on MIRI via the Regulation of Mitochondrial Quality Control[D]. Beijing: China Academy of Chinese Medical Sciences, 2024. [39] JIA FF.Mechanism of Shuangshen Ningxin Capsule Regulating Mitochondrial Autophagy against Myocardial Ischemia-Reperfusion Injury in Miniature Pigs[D]. Beijing: China Academy of Chinese Medical Sciences, 2021. [40] HAO JM, CHANG LP, WANG L, et al.Mechanism of Qili Qiangxin Capsule in Treatment of Heart Failure with Preserved Ejection Fraction Based on Network Pharmacology and Experimental Verification[J]. Chinese Traditional and Herbal Drugs(中草药), 2022, 53(14): 4365-4375. [41] JIA LM, CHEN YL, JIA M, et al.Shensong Yangxin Capsule Plays a Protective Role in Myocardial Ischemia-Reperfusion Injury through Iron Death Pathway[J]. Modern Journal of Integrated Traditional Chinese and Western Medicine(现代中西医结合杂志), 2024, 33(8): 1072-1076. |
| [1] | ZHENG Haiyun, WANG Ruifen, XIONG Jie, ZHAO Fei, WANG Bin, YU Wen. Identification of in vitro and in vivo Chemical Constituents of Guipi Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2026, 23(4): 414-419. |
| [2] | LIU Jingjing, XU Beilei, WANG Qi, LIU Jing. Study on the Effect of Ginseng Radix et Rhizoma Rubra and Polygonum Multiflorum Radix Preparata Medicinal Pair on Delaying the Aging Process and Related Pathological Changes in SAMP8 Mice [J]. Chinese Journal of Pharmacovigilance, 2026, 23(2): 127-133. |
| [3] | LIU Lianlian, WANG Chengxiang, GUO Shanshan, YU Huiyong, NIE Weicheng, CHHEN Tianyun, LI Lei. Relationships between Ginseng,Salvia Miltiorrhiza and Retinoic Acid and Key Differential Genes of Severe Influenza and Immune Infiltration Mechanisms Using Bioinformatics [J]. Chinese Journal of Pharmacovigilance, 2025, 22(11): 1271-1275. |
| [4] | ZHAO Ziyi, LU Chengjin, ZHANG Xiaomeng, HUANG Huaijuan, ZHANG Bing. Bleeding Risk and Interactions of Warfarin Combined with Traditional Chinese Medicine [J]. Chinese Journal of Pharmacovigilance, 2025, 22(11): 1217-1222. |
| [5] | ZHENG Haiyun, ZHANG Wen, WANG Shaonan, ZHAO Haiyu, DU Shouying. Anti-fatigue effects and mechanism of ginseng combined with caffeine in rats [J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 863-870. |
| [6] | LI Hongchang, GE Yunxuan, WANG Ningning, ZHOU Wei, WANG Yuguang, MA Zengchun, GAO Yue. Research progress in roles of ginseng combined with Radix Aconiti Carmichaeli in reducing toxicity and increasing efficiency in myocardial cells [J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 601-605. |
| [7] | LIU Jingjing, XU Beilei, YANG Jianbo, WANG Ying, LIU Yue, WANG Qi, MA Shuangcheng. HT22 Cell and Caenorhabditis elegans models of the anti-aging effect of Ginseng Radix et Rhizoma Rubra and Polygonum Multiflorum Radix preparata medicinal pair [J]. Chinese Journal of Pharmacovigilance, 2023, 20(6): 629-633. |
| [8] | LIU Jingjing, DAI Zhong, YANG Jianbo, WANG Ying, XU Beilei, LIU Yue, WANG Qi, MA Shuangcheng. Spectrum-fect relationship of Ginseng Radix et Rhizoma Rubra and Polygonum Multiflorum Radix Preparata medicinal pair in protection of nerve cells [J]. Chinese Journal of Pharmacovigilance, 2023, 20(6): 623-628. |
| [9] | CHENG Fengjingming, LYU Jian, XIE Yanming. Efficacy and safety of compound salvia miltiorrhiza spray/aerosol for angina pectoris due to coronary artery disease: a Meta analysis [J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 536-543. |
| [10] | LIU Jie, LIU Shengwei, REN Zhongyang, DING Ling, CHEN Chang, HU Yi. Effects of Panax notoginseng on gene expressions in rats with cerebral ischemia-reperfusion injury based on bioinformatics [J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 454-459. |
| [11] | ZHANG Hongwei, LI Yuanyuan, XIE Yanming, MA Xiaochang, WANG Lianxin, WEI Ruili, SUN Linxi, XU Hongyan, ZHUANG Yan. The drug combination of Danshen Ligustrazine injection in the real world [J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 851-856. |
| [12] | XIE Guanghui, MA Zengchun, MEI Yu, ZHANG Xuemei, TAN Hongling, GAO Yue. Evaluation of Pharmacokinetics of Aconiti Lateralis Radix of Shenfu Prescription in Rats with Heart Failure [J]. Chinese Journal of Pharmacovigilance, 2021, 18(7): 632-636. |
| [13] | HAO Lei, LI Jun-shan, PENG Xin-hua, WANG Xiao-kang, GAO Hui-qin, JIANG Guo-zhi, LI Zhen-jiang. Establishment of Rapid Quantitative Analysis of Water in Salvia Miltiorrhiza by Near Infrared Diffuse Reflectance Spectroscopy [J]. Chinese Journal of Pharmacovigilance, 2016, 13(8): 464-467. |
| [14] | JIA Jing-jing, MAO Xin, CHEN Ying, FU Ying-jie, HAN Shu-xian, WANG Zhi-min, LIAO Fu-long, YOU Yun. Effects of Salvia Miltiorrhiza and Exercise on Blood Stasis Aged Rat Model and Its Mechanism [J]. Chinese Journal of Pharmacovigilance, 2016, 13(2): 65-69. |
| [15] | JIN Jian, JIN Zhi-gui, XIAO Zhong-ge, WU Fei-hua. Analysis of 153 Cases of Adverse Drug Reaction Caused by Salvia miltiorrhiza [J]. Chinese Journal of Pharmacovigilance, 2010, 7(6): 370-371. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||